Dr. Lars Wegner, M.D., has been appointed as Evaxion's new CEO alongside his current role as a Board Member. With extensive experience in the vaccine industry, including senior positions at Pfizer and Bavarian Nordic, Lars brings valuable insights. He has a history of involvement in start-ups and is a Founding Investor of Evaxion. Lars will lead the company's growth and leverage his expertise to help Evaxion achieve its goals, while Niels Møller transitions to the roles of COO and CMO.